FERMT2 and nonpapillary renal cell carcinoma: Interestingly, compared to those in other organs, FERMT2 and COPG1 in normal kidney tissue were only moderately expressed, and their gene effect ranges were quite different between the RNAi and CRISPR/Cas9 screening groups in ccRCC cell lines.